BeriCos® DCP: Advanced Self-Developed Whitening Ingredient for Full-spectrum Pigmentation Correction
Struggling with stubborn melasma, uneven skin tone, post-inflammatory dark spots and dull photodamaged skin?
Meet BeriCos® DCP (Dimethylmethoxy Chromanyl Palmitate) — our independently researched, developed and manufactured premium skin-brightening raw material that rewrites the logic of safe and efficient whitening skincare. Unlike common generic brightening ingredients on the market, BeriCos® DCP integrates dual enzyme inhibition, source melanin suppression, clinical verified whitening efficacy, targeted chloasma fading and powerful cell protection in one molecule, becoming an all-round star ingredient for high-end anti-pigmentation skincare formulas.
Product Name: BeriCos® DCP
INCI Name: Dimethylmethoxy Chromanyl Palmitate
Cas No.: 1105025-85-1
Appearance: White to off-white powder
Melting point: 43-45 ℃
Purity: ≥99.3%
Molecular weight: 446.6
Function: Whitening and spot removal, skin brightening, sunscreen, light protection
1. Independent R&D and In-house Production, Stable and Customizable Supply
BeriCos® DCP Dimethylmethoxy Chromanyl Palmitate is fully self-developed and independently produced by our professional cosmetic ingredient laboratory and production base. We control the whole industrial chain from molecular optimization, synthesis process improvement to finished purification and quality testing. This in-house manufacturing model eliminates intermediate links, ensures ultra-high raw material purity, stable batch consistency and excellent formula compatibility, and supports customized processing solutions for different skincare formulations, bringing reliable cost and quality advantages for brand partners.
2. Dual Tyrosinase Inhibition, Block Pigmentation Root Cause
Most whitening ingredients only target mushroom tyrosinase for in-vitro testing, while BeriCos® DCP Dimethylmethoxy Chromanyl Palmitate delivers dual-target inhibition effect. It powerfully inhibits both mushroom tyrosinase and endogenous human tyrosinase in real human skin. As the core rate-limiting enzyme of melanin synthesis, tyrosinase directly dominates melanin generation. By restraining tyrosinase activity efficiently, DCP cuts off the initial trigger of skin pigmentation fundamentally, avoiding invalid brightening caused by single enzyme targeting limitation.
3. Block Whole-process Melanogenesis & Visible Clinical Whitening Performance
Beyond enzyme inhibition, BeriCos® DCP Dimethylmethoxy Chromanyl Palmitate suppresses the complete melanogenesis pathway in epidermal melanocytes, reducing melanin synthesis, transport and deposition comprehensively. Authorized human clinical trials have proven its significant and rapid whitening efficacy: continuous use effectively brightens overall skin tone, fades dullness, and makes skin luminous and even visibly. Meanwhile, it shows outstandingchloasma removal effect, targeting stubborn deep-seated melasma that is hard to improve by ordinary brightening ingredients, gradually diluting patchy pigmentation and repairing mottled skin tone.
4. Powerful Skin Cell Protection, Antioxidant & Anti-photoaging Bonus Benefit
BeriCos® DCP Dimethylmethoxy Chromanyl Palmitate is not merely a whitening agent. It owns excellent antioxidant activity to protect skin cells from oxidative stress, UV-induced photodamage and lipid peroxidation. It stabilizes cell activity, reduces free radical damage, repairs fragile skin barrier caused by long-term sun exposure and pigmentation problems. It realizes integrated skincare: whitening + spot fading + cell protection + anti-photoaging, avoiding skin irritation and barrier damage caused by single high-efficiency whitening ingredients.
Safe, efficient and multi-functional, BeriCos® DCP Dimethylmethoxy Chromanyl Palmitate is the ideal core ingredient for whitening serums, spot-removing creams, anti-melasma skincare products and after-sun repair formulas.
📩 Contact us now for free samples, full efficacy data sheets and formulation guidance!
#BeriCosDCP #WhiteningIngredient #CosmeticRawMaterial #MelasmaTreatment #TyrosinaseInhibitor #SkinBrightening
Comments
Post a Comment